Cleared Traditional

K183118 - dpl SpotLite (FDA 510(k) Clearance)

Feb 2019
Decision
90d
Days
Class 2
Risk

K183118 is an FDA 510(k) clearance for the dpl SpotLite. This device is classified as a Over-the-counter Powered Light Based Laser For Acne (Class II - Special Controls, product code OLP).

Submitted by Led Technologies, Inc. (Greenwood Village, US). The FDA issued a Cleared decision on February 7, 2019, 90 days after receiving the submission on November 9, 2018.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4810. The Device Is Intended For Over-the-counter (otc) Use To Treat Patients With Mild To Moderate Acne Vulgaris. The Device Is Intended To Emit Energy In The Red And Blue Region Of The Spectrum, Specifically Indicated To Treat Mild To Moderate Acne Vulgaris..

Submission Details

510(k) Number K183118 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 2018
Decision Date February 07, 2019
Days to Decision 90 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code OLP - Over-the-counter Powered Light Based Laser For Acne
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4810
Definition The Device Is Intended For Over-the-counter (otc) Use To Treat Patients With Mild To Moderate Acne Vulgaris. The Device Is Intended To Emit Energy In The Red And Blue Region Of The Spectrum, Specifically Indicated To Treat Mild To Moderate Acne Vulgaris.